COCP

Cocrystal Pharma (COCP)

About Cocrystal Pharma (COCP)

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.

Details

Daily high

$1.84

Daily low

$1.79

Price at open

$1.76

52 Week High

$3.10

52 Week Low

$1.32

Market cap

18.2M

Dividend yield

0.00%

Volume

11,659

Avg. volume

14,237

P/E ratio

-1.02

Cocrystal Pharma News